is glp 1 tirzepatide Beyond glycemia: Comparing to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders Insights into the Mechanism of
Description
Enjoy guided treatments with our healthcare experts.

The SELECT trial, published in The Lancet (October 22, 2025), provides a landmark analysis confirming that the cardioprotective

GLP-1 receptor agonists like semaglutide (Ozempic) can be used safely in patients with compensated (Child-Pugh Class A) cirrhosis but should be avoided in de...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed treatment.

Male MC4R-KO mice were fed WD for 6 weeks starting from 22 weeks of age for disease induction and were administered drugs for 7 weeks with WD feeding, for a total duration of 13 weeks
